Study finds anticancer drugs, specifically antimetabolites and molecular targeted therapies, may reduce the risk of Alzheimer’s type dementia but not vascular dementia.
Anticancer drugs show promise in reducing Alzheimer’s dementia risk
- Post author:
- Post published:August 1, 2024
- Post category:uncategorized